brazerzkidaismall.blogg.se

Over the counter inhaler
Over the counter inhaler






  • FDA is warning that some individuals are abusing or misusing the over-the-counter (OTC) nasal decongestant propylhexedrine, including by ingesting or injecting it which can result in serious cardiac and psychiatric adverse events and possibly death.
  • over the counter inhaler

    You can sign up for email alerts about Drug Safety Communications on medicines or medical specialties of interest to you.To help FDA track safety issues with medicines, report side effects from propylhexedrine or other medicines to the FDA MedWatch program, using the information in the "Contact FDA" box at the bottom of this page.You can fill out and print a copy of My Medicine Record. It is helpful to keep a list of all your current medicines in your wallet or another location where it is easily retrieved. Always tell your health care professionals about all the medicines you are taking, including OTC medicines such as propylhexedrine, vitamins, and other supplements.

    Over the counter inhaler how to#

    Ask a pharmacist or your health care professional if you have any questions about propylhexedrine, how to use it, or whether another medicine you are taking may interact with it.

    over the counter inhaler

  • Do not share inhalers, as use of the product by more than one person may spread infection.
  • Prolonged use may cause nasal congestion to recur or worsen.
  • Do not exceed recommended dosage or use for more than 3 days.
  • Only use propylhexedrine according to the directions listed on the Drug Facts label.
  • Rapid heartbeat or abnormal heart rhythm.
  • Severe anxiety or agitation, confusion, hallucinations, or paranoia.
  • Seek medical attention immediately by calling 911 or poison control at 1-80 for anyone using propylhexedrine who experiences the following:.
  • These include fast or abnormal heart rhythms, high blood pressure, heart attack, heart failure, agitation, delusions, paranoia, hallucinations, and death even after a few hours of abuse or misuse.
  • FDA is warning that abuse or misuse of propylhexedrine, an over-the-counter (OTC) nasal decongestant, can lead to serious heart and mental health problems.
  • †The cases were reported to the FDA Adverse Event Reporting System (FAERS) database. * National Electronic Injury Surveillance System-Cooperative Adverse Event Surveillance Project (NEISS-CADES). 6-25 These publications showed similar findings compared to the cases identified from poison control calls and emergency department visits and the cases reported to FDA. We also reviewed 49 case reports and an observational study published in the medical literature. Most of the deaths resulted from propylhexedrine abuse in combination with other substances. Of these 60 cases, 23 experienced life-threatening adverse events or hospitalization, and nine died. Some harms occurred several hours after abuse. There are likely additional cases that we have not identified.

    over the counter inhaler

    † An additional seven cases of serious adverse events related to propylhexedrine abuse were found from emergency department visits * in the 3 years between January 1, 2016, and December 31, 2018. Among the 460 cases, 21 had severe outcomes (adverse effects that were life-threatening), with 13 resulting in intensive care admissions.įifty-three cases of propylhexedrine abuse and misuse were voluntarily reported to FDA in the several decades from January 1969 through January 31, 2020. The most commonly reported side effects included rapid heart rate, agitation, high blood pressure, chest pain, tremor, hallucinations, delusions, confusion, nausea, and vomiting. Most of the cases involved abuse or misuse of propylhexedrine alone without other substances.

    over the counter inhaler

    Annual cases increased from 11 cases in 2011 to 74 cases in 2019, with abuse cases making up the majority of this increase. poison control centers documented 460 cases of propylhexedrine abuse (415 cases) or misuse (45 cases). poison control center calls, case reports submitted to FDA, the medical literature, and emergency department visits.






    Over the counter inhaler